9H1D
 
 | | Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibitor AD015 | | Descriptor: | (2~{S},5~{R})-5-(4-methylphenyl)-1-[2-[[(2~{S})-3-phenyl-2-sulfanyl-propanoyl]amino]ethanoyl]pyrrolidine-2-carboxylic acid, 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | | Authors: | Cozier, G.E, Acharya, K.R. | | Deposit date: | 2024-10-09 | | Release date: | 2025-04-16 | | Method: | X-RAY DIFFRACTION (1.8 Å) | | Cite: | Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C-Domain-Selective/Neprilysin Inhibitors.
J.Med.Chem., 68, 2025
|
|
9F35
 | |
9FCV
 | |
9EOL
 | |
9F7V
 | |
9F7O
 | |
9EWF
 | | Cholera toxin B subunit in complex with fluorinated GM1 | | Descriptor: | (2R,3S,4S,5R,6R)-6-dodecoxy-5-fluoranyl-2-(hydroxymethyl)oxane-3,4-diol, 2-deoxy-2-fluoro-beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-galactopyranose-(1-4)-[N-acetyl-alpha-neuraminic acid-(2-3)]beta-D-galactopyranose, Cholera enterotoxin subunit B | | Authors: | Fan, J, Koehnke, J. | | Deposit date: | 2024-04-03 | | Release date: | 2025-02-26 | | Method: | X-RAY DIFFRACTION (2.1 Å) | | Cite: | Probing the Origin of Affinity in the GM1-Cholera Toxin Complex through Site-Selective Editing with Fluorine.
Acs Cent.Sci., 10, 2024
|
|
9KC9
 | | Cryo-EM structure of docked mouse bestrophin-1 in a partial open state | | Descriptor: | Bestrophin-1,Soluble cytochrome b562, CALCIUM ION, CHLORIDE ION | | Authors: | Lim, H.H, Kim, K.W, Ko, A. | | Deposit date: | 2024-11-01 | | Release date: | 2025-03-19 | | Last modified: | 2025-04-02 | | Method: | ELECTRON MICROSCOPY (3.1 Å) | | Cite: | Cryo-EM structures of mouse bestrophin 1 channel in closed and partially open conformations.
Mol.Cells, 48, 2025
|
|
9JI6
 | | CYP105A1 R84A complexed with diclofenac (DIF) | | Descriptor: | 1,2-ETHANEDIOL, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, 2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID, ... | | Authors: | Mikami, B, Takita, T, Sakaki, T, Yasuda, K, Wada, M, Yasukawa, K. | | Deposit date: | 2024-09-11 | | Release date: | 2025-04-23 | | Method: | X-RAY DIFFRACTION (1.55 Å) | | Cite: | Structure-Function Analysis of Streptomyces griseolus CYP105A1 in the Metabolism of Nonsteroidal Anti-inflammatory Drugs.
Biochemistry, 64, 2025
|
|
9JIP
 | | CYP105A1 R84A complexed with flufenamic acid (FLF) | | Descriptor: | 1,2-ETHANEDIOL, 2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID, PROTOPORPHYRIN IX CONTAINING FE, ... | | Authors: | Mikami, B, Takita, T, Sakaki, T, Yasuda, K, Wada, M, Yasukawa, K. | | Deposit date: | 2024-09-12 | | Release date: | 2025-04-23 | | Method: | X-RAY DIFFRACTION (1.68 Å) | | Cite: | Structure-Function Analysis of Streptomyces griseolus CYP105A1 in the Metabolism of Nonsteroidal Anti-inflammatory Drugs.
Biochemistry, 64, 2025
|
|
9JHW
 | | CYP105A1 complexed with diclofenac (DIF) | | Descriptor: | 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, 2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID, PROTOPORPHYRIN IX CONTAINING FE, ... | | Authors: | Mikami, B, Takita, T, Sakaki, T, Yasuda, K, Wada, M, Yasukawa, K. | | Deposit date: | 2024-09-10 | | Release date: | 2025-04-23 | | Method: | X-RAY DIFFRACTION (1.4 Å) | | Cite: | Structure-Function Analysis of Streptomyces griseolus CYP105A1 in the Metabolism of Nonsteroidal Anti-inflammatory Drugs.
Biochemistry, 64, 2025
|
|
9JI1
 | | CYP105A1 complexed with flufenamic acid (FLF) | | Descriptor: | 1,2-ETHANEDIOL, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, 2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID, ... | | Authors: | Mikami, B, Takita, T, Sakaki, T, Yasuda, K, Wada, M, Yasukawa, K. | | Deposit date: | 2024-09-11 | | Release date: | 2025-04-23 | | Method: | X-RAY DIFFRACTION (1.47 Å) | | Cite: | Structure-Function Analysis of Streptomyces griseolus CYP105A1 in the Metabolism of Nonsteroidal Anti-inflammatory Drugs.
Biochemistry, 64, 2025
|
|
